EFFECT OF DOPAMINE AGONIST WITHDRAWAL AFTER LONG-TERM THERAPY IN PROLACTINOMAS: Studies with High-definition Computerised Tomography
- 28 July 1984
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 324 (8396), 187-192
- https://doi.org/10.1016/s0140-6736(84)90480-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Drugs Five Years LaterAnnals of Internal Medicine, 1984
- HyperprolactinemiaAmerican Journal Of Medicine, 1983
- Pergolide for the Treatment of Pituitary Tumors Secreting Prolactin or Growth HormoneNew England Journal of Medicine, 1983
- Recurrence of Hyperprolactinemia after Selective Transsphenoidal Adenomectomy in Women with ProlactinomaNew England Journal of Medicine, 1983
- Reduction in size of prolactin-secreting tumours in men treated with pergolide.BMJ, 1982
- HYPERPROLACTINAEMIA IN MEN?RESPONSE TO BROMOCRIPTINE THERAPYThe Lancet, 1982
- TREATMENT OF HYPERPROLACTINAEMIA WITH PERGOLIDE MESYLATE: ACUTE EFFECTS AND PRELIMINARY EVALUATION OF LONG-TERM TREATMENTThe Lancet, 1981
- Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*Journal of Clinical Endocrinology & Metabolism, 1981
- Prolactin‐Secreting pituitary tumorsAnnals of Neurology, 1977
- Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptineBMJ, 1972